Bone and Extracellular Signal-Related Kinase 5 (ERK5)

被引：0
|
作者：
Wen, Lei [1 ,2 ,3 ]
Liu, Zirui [1 ,2 ]
Zhou, Libo [1 ,2 ]
Liu, Zhongcheng [1 ,2 ]
Li, Qingda [1 ,2 ]
Geng, Bin [1 ,2 ]
Xia, Yayi [1 ,2 ]
机构：
[1] Lanzhou Univ, Hosp & Clin Med Sch 2, Dept Orthoped, Lanzhou 730030, Peoples R China
[2] Orthoped Clin Med Res Ctr, Intelligent Orthoped Ind Technol Ctr Gansu Prov, Orthoped Clin Med Res Ctr Gansu Prov, Intelligent Orthoped Ind Technol Ctr Gansu Prov,De, Lanzhou 730030, Peoples R China
[3] Yunnan Univ, Dept Orthoped & Trauma Surg, Affiliated Hosp, Kunming 650032, Peoples R China
来源：
BIOMOLECULES | 2024年 / 14卷 / 05期
基金：
中国国家自然科学基金;
关键词：
bone; homeostasis; ERK5; cancer; ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELL-PROLIFERATION; SUPPRESSES TUMOR-GROWTH; REGULATED KINASE-5; BREAST-CANCER; TARGETED DELETION; PROSTATE-CANCER; INDUCED APOPTOSIS; PATHWAY;
D O I：
10.3390/biom14050556
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Bones are vital for anchoring muscles, tendons, and ligaments, serving as a fundamental element of the human skeletal structure. However, our understanding of bone development mechanisms and the maintenance of bone homeostasis is still limited. Extracellular signal-related kinase 5 (ERK5), a recently identified member of the mitogen-activated protein kinase (MAPK) family, plays a critical role in the pathogenesis and progression of various diseases, especially neoplasms. Recent studies have highlighted ERK5's significant role in both bone development and bone-associated pathologies. This review offers a detailed examination of the latest research on ERK5 in different tissues and diseases, with a particular focus on its implications for bone health. It also examines therapeutic strategies and future research avenues targeting ERK5.
引用
收藏
页数：24
相关论文
共 50 条
  • [1] Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells
    Dinev, D
    Jordan, BWA
    Neufeld, B
    Lee, JD
    Lindemann, D
    Rapp, UR
    Ludwig, S
    EMBO REPORTS, 2001, 2 (09) : 829 - 834
  • [2] Regulation of the biology of cholangiocarcinoma (CCA) cells by the extracellular-signal regulated kinase 5 (ERK5)
    Gentilini, Alessandra
    Lori, Giulia
    Caligiuri, Alessandra
    Rovida, Elisabetta
    Raggi, Chiara
    Di Maira, Giovanni
    Banales, Jesus M.
    Di Matteo, Sabina
    Alvaro, Domenico
    Marra, Fabio
    JOURNAL OF HEPATOLOGY, 2020, 73 : S637 - S637
  • [3] Regulation of the biology of cholangiocarcinoma (CCA) cells by Extracellular-signal-regulated kinase 5 (ERK5)
    Gentilini, A.
    Lori, G.
    Caligiuri, A.
    Rovida, E.
    Raggi, C.
    Di Maira, G.
    Banales, J. M.
    Di Matteo, S.
    Alvaro, D.
    Marra, F.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E51 - E51
  • [4] Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) Module
    Glatz, Gabor
    Gogl, Gergo
    Alexa, Anita
    Remenyi, Attila
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (12) : 8596 - 8609
  • [5] Role of extracellular signal-related kinase (Erk) 1 in the regulation of neuroinflammation
    I Bendix
    CF Pfueller
    T Leuenberger
    V Siffrin
    U Schulze-Topphoff
    C Loddenkemper
    F Zipp
    S Waiczies
    Cell Communication and Signaling, 7 (Suppl 1)
  • [6] Role of extracellular signal-regulated kinase 5 (ERK5) in human breast cancer.
    Watson, C. M.
    Kipgen, D.
    Orange, C.
    Tovey, S.
    Cooke, T. G.
    Edwards, J.
    Leung, H. Y.
    CANCER RESEARCH, 2009, 69 (02) : 264S - 264S
  • [7] Glucose-Induced Extracellular Matrix Production is Negatively Regulated by Extracellular Signal Regulated Kinase 5 (ERK5)
    Wu, Yuexiu
    Feng, Biao
    Chen, Shali
    Chakrabarti, Subrata
    DIABETES, 2012, 61 : A443 - A443
  • [8] Glucose-Induced Extracellular Matrix Production is Negatively Regulated by Extracellular Signal Regulated Kinase 5 (ERK5)
    Wu, Yuexiu
    Feng, Biao
    Chen, Shali
    Chakrabarti, Subrata
    DIABETES, 2012, 61 : A443 - A443
  • [9] Development of extracellular signal-regulated kinase 5 (ERK5) inhibitors for anti-cancer therapy
    Myers, S.
    Martin, N.
    Bawn, R.
    Blackburn, T.
    Barrett, L.
    Reuillon, T.
    Golding, B.
    Griffin, R.
    Hammonds, T.
    Hardcastle, I.
    Leung, H.
    Newell, D.
    Rigoreau, L.
    Wong, A.
    Cano, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 141 - 141
  • [10] Stretching the limits of extracellular signal-related kinase (ERK) signaling - Cell mechanosensing to ERK activation
    Hirashima, Tsuyoshi
    Hino, Naoya
    Aoki, Kazuhiro
    Matsuda, Michiyuki
    CURRENT OPINION IN CELL BIOLOGY, 2023, 84
12345